Sarcomas of the heart as a difficult interdisciplinary problem.
Cardiac tumors are assumed to be a rare entity. Metastases to the heart are more frequent than primary lesions. Sarcomas make up the majority of cardiac malignant neoplasms. Among them angiosarcoma is the most common and associated with the worst prognosis. Malignant fibrous histiocytoma comprises the minority of cardiac sarcomas and has uncertain etiology as well as pathogenesis. Transthoracic echocardiography remains the widely available screening examination for the initial diagnosis of a cardiac tumor. The clinical presentation is non-specific and the diagnosis is established usually at an advanced stage of the disease. Sarcomas spread preferentially through blood due to their immature vessels without endothelial lining. Surgery remains the method of choice for treatment. Radicalness of the excision is still the most valuable prognostic factor. Adjuvant therapy is unlikely to be effective. The management of cardiac sarcomas must be individualized due to their rarity and significant differences in the course of disease.
Department of Cardiac Surgery, Chair of Cardiology and Cardiac Surgery, Medical University of Lodz, Poland ; Military Teaching Hospital - Veterans Central Hospital, Lodz, Poland.
Stanisław
S
Ostrowski
Department of Cardiac Surgery, Chair of Cardiology and Cardiac Surgery, Medical University of Lodz, Poland ; Military Teaching Hospital - Veterans Central Hospital, Lodz, Poland.
Anna
A
Marcinkiewicz
Military Teaching Hospital - Veterans Central Hospital, Lodz, Poland.
Anna
A
Kośmider
Department of Cardiac Surgery, Chair of Cardiology and Cardiac Surgery, Medical University of Lodz, Poland ; Military Teaching Hospital - Veterans Central Hospital, Lodz, Poland.
Ryszard
R
Jaszewski
angiosarcoma; cardiac tumors; surgery; transthoracic echocardiography